Kanawha Capital Management LLC Raises Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Kanawha Capital Management LLC raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 20.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,384 shares of the financial services provider’s stock after buying an additional 1,432 shares during the quarter. Kanawha Capital Management LLC’s holdings in iShares Biotechnology ETF were worth $1,221,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of IBB. Blue Fin Capital Inc. lifted its position in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares in the last quarter. Security National Bank of SO Dak lifted its stake in iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after acquiring an additional 75 shares during the period. SPC Financial Inc. lifted its stake in iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after acquiring an additional 75 shares during the period. Werba Rubin Papier Wealth Management boosted its holdings in shares of iShares Biotechnology ETF by 2.7% during the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after acquiring an additional 76 shares during the last quarter. Finally, Main Street Financial Solutions LLC grew its stake in shares of iShares Biotechnology ETF by 1.0% in the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after acquiring an additional 82 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $142.78 on Monday. iShares Biotechnology ETF has a twelve month low of $113.56 and a twelve month high of $150.57. The company’s 50 day moving average is $145.02 and its 200 day moving average is $140.46.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.